CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 93 filers reported holding CARA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,283 | -40.6% | 4,335 | 0.0% | 0.00% | – |
| Q2 2023 | $12,268 | -97.4% | 4,335 | -95.5% | 0.00% | – |
| Q1 2023 | $468,209 | -59.5% | 95,358 | -11.4% | 0.00% | – |
| Q4 2022 | $1,155,753 | +17.2% | 107,612 | +2.2% | 0.00% | – |
| Q3 2022 | $986,000 | +9.3% | 105,343 | +6.6% | 0.00% | – |
| Q2 2022 | $902,000 | -25.9% | 98,775 | -1.4% | 0.00% | – |
| Q1 2022 | $1,218,000 | -1.1% | 100,222 | -0.9% | 0.00% | – |
| Q4 2021 | $1,232,000 | -18.2% | 101,138 | +3.8% | 0.00% | – |
| Q3 2021 | $1,506,000 | +15.8% | 97,461 | +7.0% | 0.00% | – |
| Q2 2021 | $1,300,000 | +697.5% | 91,085 | +1107.9% | 0.00% | – |
| Q1 2021 | $163,000 | +44.2% | 7,541 | +0.5% | 0.00% | – |
| Q4 2020 | $113,000 | +17.7% | 7,507 | 0.0% | 0.00% | – |
| Q3 2020 | $96,000 | -40.0% | 7,507 | -19.9% | 0.00% | – |
| Q2 2020 | $160,000 | +37.9% | 9,373 | +6.2% | 0.00% | – |
| Q1 2020 | $116,000 | -31.8% | 8,826 | -16.0% | 0.00% | – |
| Q4 2019 | $170,000 | +1.2% | 10,513 | +13.9% | 0.00% | – |
| Q3 2019 | $168,000 | -5.6% | 9,227 | +11.5% | 0.00% | – |
| Q2 2019 | $178,000 | +54.8% | 8,272 | +41.1% | 0.00% | – |
| Q1 2019 | $115,000 | +59.7% | 5,863 | +5.9% | 0.00% | – |
| Q4 2018 | $72,000 | -45.5% | 5,538 | 0.0% | 0.00% | – |
| Q3 2018 | $132,000 | +69.2% | 5,538 | +36.2% | 0.00% | – |
| Q2 2018 | $78,000 | +25.8% | 4,066 | -19.2% | 0.00% | – |
| Q1 2018 | $62,000 | -29.5% | 5,031 | -28.8% | 0.00% | – |
| Q4 2017 | $88,000 | -21.4% | 7,064 | -14.2% | 0.00% | – |
| Q3 2017 | $112,000 | -5.1% | 8,233 | +14.9% | 0.00% | – |
| Q2 2017 | $118,000 | +0.9% | 7,167 | +10.4% | 0.00% | – |
| Q1 2017 | $117,000 | +85.7% | 6,489 | -3.5% | 0.00% | – |
| Q4 2016 | $63,000 | +110.0% | 6,723 | +81.2% | 0.00% | – |
| Q3 2016 | $30,000 | +66.7% | 3,710 | 0.0% | 0.00% | – |
| Q2 2016 | $18,000 | -21.7% | 3,710 | 0.0% | 0.00% | – |
| Q1 2016 | $23,000 | -61.0% | 3,710 | 0.0% | 0.00% | – |
| Q4 2015 | $59,000 | – | 3,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 622,140 | $10,489,000 | 45.13% |
| RHO CAPITAL PARTNERS INC | 2,668,057 | $44,983,000 | 15.47% |
| Opaleye Management Inc. | 427,000 | $7,199,000 | 3.01% |
| DAFNA Capital Management LLC | 169,331 | $2,855,000 | 2.54% |
| Private Capital Advisors, Inc. | 246,850 | $4,162,000 | 1.80% |
| WALL STREET ASSOCIATES | 192,300 | $3,242,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 1,212,578 | $20,444,000 | 0.87% |
| Virtus ETF Advisers LLC | 17,299 | $292,000 | 0.80% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 618,140 | $10,422,000 | 0.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 197,820 | $3,335,000 | 0.49% |